These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 31595822

  • 21. Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case report.
    Schoenfeld JD, Odejide OO, Wirth LJ, Chan AW.
    Anticancer Res; 2012 May; 32(5):1743-6. PubMed ID: 22593455
    [Abstract] [Full Text] [Related]

  • 22. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
    Zhou W, Yue Y, Zhang X.
    Front Endocrinol (Lausanne); 2021 May; 12():748023. PubMed ID: 34790169
    [Abstract] [Full Text] [Related]

  • 23. The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study.
    Onoda N, Sugino K, Higashiyama T, Kammori M, Toda K, Ito K, Yoshida A, Suganuma N, Nakashima N, Suzuki S, Tsukahara K, Noguchi H, Koizumi M, Nemoto T, Hara H, Miyauchi A, Sugitani I.
    Thyroid; 2016 Sep; 26(9):1293-9. PubMed ID: 27484330
    [Abstract] [Full Text] [Related]

  • 24. Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis.
    Yin Y, Wang L, Huang C.
    Endocrine; 2024 Jul; 85(1):250-257. PubMed ID: 38183567
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
    Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ, KEYNOTE-040 investigators.
    Lancet; 2019 Jan 12; 393(10167):156-167. PubMed ID: 30509740
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of surgery in the treatment of thyroid anaplastic carcinoma in the elderly.
    Polistena A, Monacelli M, Lucchini R, Triola R, Conti C, Avenia S, Rondelli F, Bugiantella W, Barillaro I, Sanguinetti A, Avenia N.
    Int J Surg; 2014 Jan 12; 12 Suppl 2():S170-S176. PubMed ID: 25167852
    [Abstract] [Full Text] [Related]

  • 31. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
    Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S.
    World J Surg; 2012 Jun 12; 36(6):1247-54. PubMed ID: 22311136
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
    Wu SS, Lamarre ED, Yalamanchali A, Brauer PR, Hong H, Reddy CA, Yilmaz E, Woody N, Ku JA, Prendes B, Burkey B, Nasr C, Skugor M, Heiden K, Chute DJ, Knauf JA, Campbell SR, Koyfman SA, Geiger JL, Scharpf J.
    JAMA Otolaryngol Head Neck Surg; 2023 Apr 01; 149(4):300-309. PubMed ID: 36757708
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
    Mohebati A, Dilorenzo M, Palmer F, Patel SG, Pfister D, Lee N, Tuttle RM, Shaha AR, Shah JP, Ganly I.
    Ann Surg Oncol; 2014 May 01; 21(5):1665-70. PubMed ID: 24554064
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma.
    Shah MA, Bennouna J, Doi T, Shen L, Kato K, Adenis A, Mamon HJ, Moehler M, Fu X, Cho BC, Bordia S, Bhagia P, Shih CS, Desai A, Enzinger P.
    Future Oncol; 2021 Apr 01; 17(10):1143-1153. PubMed ID: 33533655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.